To Enrich Its Existing Mental Property Portfolio, the Corporation Filed an Extra U.S. Provisional Patent Software Directed to: Alternate Pharmaceutical Cannabinoid Shipping and delivery Programs
NEW YORK, NY, March 22, 2021 (Globe NEWSWIRE) — by way of NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a earnings generating, diversified lifestyle sciences business, with a proprietary line of CBD & CBG infused Health supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant), added products offerings, as nicely as an ongoing Pharmaceutical Improvement initiative, these days announced that on March 17, 2021, the Organization converted its U.S. Provisional Patent Software (submitted on March 17, 2020) to a U.S. Non-Provisional Patent Application. This Non-Provisional Patent Application relates to the Company’s proposed Pharmaceutical Cannabinoid Chewing Gum Delivery System – currently being produced to take care of: Nausea Derived from Lively Chemotherapy Cure.
Also on March 17, 2021, to enhance its existing mental residence (“IP”) portfolio, the Corporation filed an supplemental U.S. Provisional Patent Application directed to: Option Pharmaceutical Cannabinoid Supply Programs.
The Enterprise continues to realize vital and content progress with respect to its ongoing Pharmaceutical improvement initiatives. The Business expects to give supplemental update(s) to shareholders (relating to clinical trials), within just the in close proximity to phrase.
ABOUT TAURIGA SCIENCES, INC.
Tauriga Sciences, Inc. (TAUG) is a income producing, diversified existence sciences enterprise, engaged in many major enterprise activities and initiatives. The enterprise manufactures and distributes various proprietary retail products and solutions and products strains, mostly targeted on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles industry phase. The key solution line, branded as Tauri-Gum™, is made up of a proprietary complement chewing gum that is Kosher certified, Halal accredited, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Flavor: Pear Bellini). The Company’s commercialization technique is composed of a broad array of retail buyers, distributors, and a rapidly-growing E-Commerce business enterprise section (E-Commerce internet site: www.taurigum.com). Remember to pay a visit to our corporate website, for more information, as nicely as inquiries, at http://www.tauriga.com
Complementary to the Company’s retail company, is its ongoing Pharmaceutical Growth initiative. This relates to the enhancement of a proposed Pharmaceutical quality model of Tauri-Gum™, for nausea regulation (specially made for the subsequent indication: Individuals Subjected to Ongoing Chemotherapy Remedy). On March 18, 2020, the Business declared that it experienced submitted a provisional U.S. patent software covering its pharmaceutical grade edition of Tauri-Gum™. The Patent, submitted with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, Approaches OF Manufacturing, AND Techniques OF TREATMENT”. On December 18, 2020 the Firm disclosed that it experienced entered into a Learn Products and services Settlement with CSTI to lead the Company’s medical growth initiatives.
The Corporation is headquartered in Wappingers Falls, New York. In addition, the Firm operates two full time E-Commerce success facilities: one situated in Montgomery, Texas and the other in Brooklyn, New York.
DISCLAIMER — Ahead-Searching Statements
This press launch has certain “forward-looking statements” as described by the Private Securities Litigation Reform Act of 1995 which signify management’s beliefs and assumptions regarding future situations. These forward-seeking statements are frequently indicated by utilizing words this sort of as “may,” “will,” “expects,” “anticipates,” thinks, “hopes,” “believes,” or strategies, and could consist of statements concerning company objectives as effectively as the attainment of selected corporate aims and milestones. Forward-looking statements are primarily based on present situation and on management’s current beliefs with regard to functions that have not happened, that could not happen, or that might take place with unique implications or timing than individuals now assumed or predicted. Actual success could differ materially from individuals expressed in forward-wanting statements thanks to recognised and not known threats and uncertainties, this kind of as are not ensures of common financial and small business ailments, the skill to properly acquire and marketplace products and solutions, customer and business enterprise intake behaviors, the capacity to consummate prosperous acquisition and licensing transactions, fluctuations in exchange fees, and other things about which Tauriga has tiny or no manage. Several of these challenges and uncertainties are talked about in greater detail in the “Risk Factors” part of Tauriga’s Variety 10-K and other periodic filings made from time to time with the Securities and Trade Commission. Such ahead-hunting statements are made only as of the day of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent functions or situation. You must not put undue reliance on these forward-seeking statements.
Tauriga Sciences, Inc.
4 Nancy Court, Suite 4
Wappingers Falls, NY 12590
Main Government Officer
Mr. Seth M. Shaw
E mail: [email protected]
Mobile # (917) 796 9926
Firm Instagram: @taurigum
Personalized Instagram: @sethsms47
Corp. Internet site: www.tauriga.com
E-Commerce Web-site: www.taurigum.com